- Report
- November 2023
- 175 Pages
Global
From €4806EUR$5,000USD£4,121GBP
- Report
- September 2019
Global
From €5161EUR$5,370USD£4,426GBP
Navelbine (vinorelbine) is a chemotherapy drug used to treat non-small cell lung cancer (NSCLC). It is a semi-synthetic vinca alkaloid derived from the Madagascar periwinkle plant. Navelbine is administered intravenously and works by interfering with the growth of cancer cells. It is typically used in combination with other drugs, such as cisplatin or carboplatin.
Navelbine is a widely used drug in the treatment of NSCLC, and is available in both generic and branded forms. It is marketed by several pharmaceutical companies, including Pfizer, Novartis, and Teva Pharmaceuticals. It is also available in combination with other drugs, such as Alimta (pemetrexed) and Taxotere (docetaxel).
The Navelbine market is highly competitive, with several companies offering similar products. Companies in the market include Pfizer, Novartis, Teva Pharmaceuticals, Eli Lilly, Merck, AstraZeneca, and Bristol-Myers Squibb. Show Less Read more